Expanding the AnVIL data hub to support diverse health data and research
Official title: Expanding the AnVIL Data Ecosystem
Funded at Broad Institute, INC. · NIH-11411352 · Data updated 2026-11-12
This grant aims to grow a cloud-based data ecosystem (AnVIL) so researchers can access, share, and analyze large, diverse health and genomic datasets across multiple clouds.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Broad Institute, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | September 19, 2018 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $3,430,001 |
| NIH project number | 5U24HG010262-09 |
| Project ID | NIH-11411352 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers, clinicians, and patient communities who contribute data or use the AnVIL platform to analyze genomic and clinical datasets.
✕Less likely to help
Direct patient benefit is not guaranteed; the project focuses on data infrastructure that supports future research and discoveries.
What this research studies
The AnVIL project will expand its data ingestion and curation to include more datasets from NHGRI initiatives and individual researchers. It will also broaden its software infrastructure to operate across multiple cloud platforms and offer a simpler, free entry tier to boost adoption. By improving tools for data analysis and enabling easier access, patients' genetic and health information can accelerate discoveries that may benefit communities. This work is designed to make high-quality data more available to scientists and clinicians, potentially speeding insights into human health and disease.
Why it matters
Potential benefit: If successful, results could lead to faster, more collaborative genomic research and potential advances in personalized medicine for participants and patients.
How similar studies have gone: Past phases showed strong data ingestion and cloud infrastructure advances; phase II aims to build on that success with broader adoption.
Where this research is happening
-
Broad Institute, INC.
Cambridge, United States Active
Researchers
- Principal investigator: Lawson, Jonathan — Broad Institute, INC.
- Study coordinator: Lawson, Jonathan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.